收藏切换
Bioequivalence of bicalutamide tablets in healthy Chinese volunteers
收藏切换
PDF
Chun-feng DU1, 2, 4, Shi-yin FENG1, 2, 4, Qin YU1, 2, 4, Lin-rui CAI1, 2, 4, Zhuo CHEN1, 2, 4, Xu SU1, 2, 4, Qing ZOU1, 2, 4, Wei-yi GUO1, 2, 4, Feng HU1, 2, 4, Dan DU1, 2, 4, Xiao-hong LIU1, 2, 4, Feng-shan LI2, 3, 4
Chinese Journal of New Drugs | 2023, 32(14) : 1452 - 1457
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(14): 1452-1457
Bioequivalence of bicalutamide tablets in healthy Chinese volunteers
Full
Chun-feng DU1, 2, 4, Shi-yin FENG1, 2, 4, Qin YU1, 2, 4, Lin-rui CAI1, 2, 4, Zhuo CHEN1, 2, 4, Xu SU1, 2, 4, Qing ZOU1, 2, 4, Wei-yi GUO1, 2, 4, Feng HU1, 2, 4, Dan DU1, 2, 4, Xiao-hong LIU1, 2, 4, Feng-shan LI2, 3, 4
Affiliations
  • 1National Institute for Drug Clinical Trials, West China Second University Hospital, Sichuan University, Chengdu 610041, China
  • 2Key Laboratory of Drug Preparation In Vitro and In Vivo Correlation Technology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
  • 3Office of Clinical Trial Ethics Committee, West China Second University Hospital, Sichuan University, Chengdu 610041, China
  • 4Key Laboratory of Birth Defects and Related Gynecological Diseases, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, China
Published: 2023-07-30
Outline
收藏切换
Objective:

To analyze the pharmacokinetics of bicalutamide (50 mg) in healthy Chinese male volunteers and to evaluate the bioequivalence of domestic generic and reference bicalutamide (CASODEX®) in healthy Chinese male volunteers.

Methods:

A randomized, open, two-cycle, two-sequence, and cross-over study with a 56-day washout period was conducted under fasting and postprandial conditions in healthy Chinese male volunteers (40 subjects/condition). Eligible subjects randomly received a single 50 mg dose of either the test or the reference formulation. A serial blood samples were collected over a 576-hour interval following drug administration. The concentrations of bicalutamide in EDTA-K2 human plasma were determined by the liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, with non-compartmental model used for pharmacokinetic analysis. The bioequivalence of the two preparations was determined according to whether the 90% confidence interval (CI) of Cmax, AUC0-t and AUC0-∞ geometric mean ratio was within the range of 80.00%~125.00%.

Results:

The pharmacokinetic parameters of the test and reference capsules under fasting condition are as follows: Cmax (1 030±196) and (898±167) ng·mL-1; AUC0-t (224 000±42 900) and (196 000±48 400) h·ng·mL-1, AUC0-∞ (243 000±56 900) and (212 000±60 100) h·ng·mL-1. The pharmacokinetic parameters of the test and reference capsules under fed condition are as follows: Cmax (1 260±164) and (1 210±153) ng·mL-1; AUC0-t (245 000±40 700) and (241 000±44 700) h·ng·mL-1; AUC0-∞ (266 000±55 700) and (259 000±57 000) h·ng·mL-1. The 90% confidential intervals of the GMRs of Cmax, AUC0-t and AUC0-∞ fall within bioequivalence criteria (80.00%~125.00%). No serious adverse event was observed.

Conclusion:

The domestic bicalutamide formulation is bioequivalent to the reference formulation CASODEX®. Both formulations are generally well tolerated.

bicalutamide  /  bioequivalence  /  prostatic cancer  /  androgen
Chun-feng DU, Shi-yin FENG, Qin YU, Lin-rui CAI, Zhuo CHEN, Xu SU, Qing ZOU, Wei-yi GUO, Feng HU, Dan DU, Xiao-hong LIU, Feng-shan LI. Bioequivalence of bicalutamide tablets in healthy Chinese volunteers[J]. Chinese Journal of New Drugs, 2023 , 32 (14) : 1452 -1457 .
Year 2023 volume 32 Issue 14
PDF
40
16
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-07-30
Article Data
Affiliations
History
  • Accepted:2022-11-14
Affiliations
    1National Institute for Drug Clinical Trials, West China Second University Hospital, Sichuan University, Chengdu 610041, China
    2Key Laboratory of Drug Preparation In Vitro and In Vivo Correlation Technology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
    3Office of Clinical Trial Ethics Committee, West China Second University Hospital, Sichuan University, Chengdu 610041, China
    4Key Laboratory of Birth Defects and Related Gynecological Diseases, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT